Home › Therapeutic areas › Renal › Delayed Graft Function

Delayed Graft Function (1 companies)

Companies with an active program in Delayed Graft Function.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
UNCY Unicycive Therapeutics Renal 1 NDA Submitted $98.9M 2